Log in to save to my catalogue

Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer in vitro

Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer in vitro

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2914516432

Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer in vitro

About this item

Full title

Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer in vitro

Publisher

Athens: Spandidos Publications

Journal title

Experimental and therapeutic medicine, 2024-01, Vol.27 (1), Article 47

Language

English

Formats

Publication information

Publisher

Athens: Spandidos Publications

More information

Scope and Contents

Contents

The present study highlighted the repositioning of the drug dapsone (DDS) for cancer therapy. Due to its mechanism of action, DDS has a dual effect as an antibiotic and as an anti-inflammatory/immunomodulator; however, at high doses, it has important adverse effects. The derivative DDS-13 [N,N'-(sulfonyl bis (4,1-phenylene)) dioctanamide] was synth...

Alternative Titles

Full title

Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer in vitro

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2914516432

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2914516432

Other Identifiers

ISSN

1792-0981

E-ISSN

1792-1015

DOI

10.3892/etm.2023.12335

How to access this item